Princess Margaret Hospital for Children is a former children's hospital and centre for paediatric research and care located in Perth, Western Australia.

During the past decade, Princess Margaret Hospital for Children conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 71 clinical trials were completed, i.e. on average, 394.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 20 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess Margaret Hospital for Children" #1 sponsor was "Children's Oncology Group" with 144 trials, followed by "National Cancer Institute (NCI)" with 34 trials sponsored, "Seqirus" with 5 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored and "Ology Bioservices" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess Margaret Hospital for Children" #1 collaborator was "National Cancer Institute (NCI)" with 149 trials as a collaborator, "Children's Oncology Group" with 5 trials as a collaborator, "Children's Cancer Group" with 3 trials as a collaborator, "Cystic Fibrosis Foundation" with 3 trials as a collaborator and "National Health and Medical Research Council, Australia" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Princess Margaret Hospital for Children" are "Leukemia" (26 trials), "Sarcoma" (20 trials), "Neuroblastoma" (15 trials), "Unspecified Childhood Solid Tumor, Protocol Specific" (14 trials) and "Lymphoma" (12 trials). Many other conditions were trialed in "Princess Margaret Hospital for Children" in a lesser frequency.

Most popular intervention types in "Princess Margaret Hospital for Children" are "Drug" (169 trials), "Biological" (87 trials), "Other" (79 trials), "Radiation" (64 trials) and "Procedure" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "etoposide" (42 trials), "cyclophosphamide" (40 trials), "filgrastim" (40 trials) and "vincristine sulfate" (34 trials). Other intervention names were less common.

The vast majority of trials in "Princess Margaret Hospital for Children" are 220 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Princess Margaret Hospital for Children". undefined are not yet recruiting, 11 are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 164 completed trials in Princess Margaret Hospital for Children, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Princess Margaret Hospital for Children, 27 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".